Feb. 19, 2015, 10:28 AM
- Thinly-traded nano cap CollabRx (CLRX +98.2%) jumps on a massive 19x surge in volume, recovering from a short-term sell-off after its initial breakout. Shares are up 132% since breaking out on February 2 in response to a potential merger with Medytox.
- Previously: CollabRx up on improved funding outlook from potential business combo (Feb. 2)
Feb. 2, 2015, 12:02 PM
- Thinly-traded nano cap CollabRx (CLRX +32.6%) moves up on a 5x surge in volume albeit on turnover of only 380K shares as investors anticipate its merger with Medytox. In mid-January the company secured short term funding from Medytox while they negotiate a possible business combination.